Why Deny Health Care?
 |
| by Robert K. Oldham, M.D. |
 |
Most Americans would agree that "Health care should be
available equally to everyone." But now the thesis of equal
availability of health care is beginning to translate into a
sub-thesis of "If everyone can't have a health-care service,
then no one should have it."
Recent medical advances have made available a variety of
in-depth approaches to the treatment of serious disorders such
as cancer, AIDS, and major organ failure that allow for
correction or a research-based attempt at correction of the
disorder. Transplantation brings forth a large number of
potential recipients, a small number of donors, and huge costs
for each kidney, heart, or liver transplant. These transplant
stories are often in the news and may involve distressing
reports of the need for a transplant in a child, a young
mother, or a productive, breadwinner father.
The relative infrequency of the transplant dilemma has
been a major saving grace. Our sympathies go to each patient,
and many of us have contributed to help a specific patient.
No effective system-wide solution to this expensive technology
and its limited availability has come forth.
Individuals who can afford to pay for these transplants
represent a major revenue stream for hospitals with transplant
services. There is little discussion when the individual has
the capability to pay for a transplant. Is it not a wonder
that the issue of restricting availability to those who can
afford the transplant hasn't been raised by ethicists? There
has been broad negative reaction to the idea of "selling"
organs, but transplant programs go forward when organs are
available for individuals who can pay for the procedure.
More difficult is the issue of a new cancer treatment or
a new approach to the devastating problem of AIDS. In both of
these situations, there has been much discussion about access
and opportunity, the cost of research and medical services,
and the issue of availability. Government and university
officials have often voiced the view that a certain number of
research-based approaches should be available through their
hospitals. Individuals should line up and wait for the
opportunity to avail themselves of these research services.
Such a system resembles the National Health Service of
Britain, except that in the United States, contacts, political
pressure, and money often can abridge a system of equal
opportunity for all. One is reminded of kidney dialysis in
its early days -- an expensive technology for which committees
were created to judge the worthiness of individuals in need.
In spite of such committees, patients with resources were
generally able to avail themselves of dialysis.
Once rejected from such a system or once on a too-long
waiting list with too little time, why restrain an individual
with resources from pursuing private options? It would seem
obvious that an individual with resources should be able to
use those resources as he or she sees fit, while alive and
able to make rational decisions. Yet, there is an increasing
call to restrain such individuals from pursuing private-sector
opportunities to gain access to new medical technologies for
the treatment of cancer or AIDS.
The arguments go something like this: "If a medical
service isn't available for everyone, should it be available
for a few? Isn't it unethical or morally repugnant for
someone with assets to be able to pursue a new, research-based
treatment approach when others, without these resources,
cannot? Shouldn't there be restraints on the private sector
in the delivery of medical services to those who wish to pay
for them?"
This thought process would indeed be bizarre if it were
applied to a vital product such as food. At the moment, no
one is crying foul if someone with resources chooses to eat
more than the minimum daily requirement. In a similar manner,
there has been no call to restrict the availability of air
conditioners for those who wish to purchase them in spite of
the obvious health advantages of air conditioning to the sick
and elderly who can't afford them. There has been no call to
remove private rooms or executive suites from hospitals where
they are available to patients with resources. There has been
no call to restrain travel by those who wish to fly to
Switzerland or Italy or to a clinical facility in the United
States for specialized medical care.
As a physician, I often receive calls from individuals
who ask if I have access to a specialized technology, a
research-based approach, for the treatment of a relative. I
am struck by the fact that the individual, often a practicing
physician, has not called me about his patients. I am struck
that such individuals often work in government or
universities. Some have been openly critical of privatesector
systems of cancer research that might provide
opportunities for those with the resources to afford them --
until someone close needs access and opportunity. What are
the ethics of one standard for a relative and a different
approach for a patient? This curious schizophrenia that
everyone should have equal access and the corollary that if
everyone can't have it, no one should, represents a dangerous
thought process.
To then translate that to a system where no one can have
access to more health care beyond a set standard would be a
grievous error. Such thinking outside of the health field is
clearly anomalous. Let's not apply a unique standard to
health-care services but let's apply the same rules of logic
to all basic services that individuals might utilize, given
their resources.
Dr. Oldham is Chairman and Scientific Director of Biotherapeutics
Inc., based in Franklin, Tennessee, a firm which conducts cancer research
for patients in the private sector. He is Director of the Biological
Therapy Institute where he conducts clinical trials of new treatments for
cancer patients. He was the first director of the National Cancer
Institute's Biological Response Modifier Program. His articles have
appeared in numerous publications, including The New England Journal
of Medicine and The Wa